 |
|
A Study of Hemophilia
MARY C. HARMON, M.D.;
ALVIN ZIPURSKY, M.D.;
MARION E. LAHEY
AMA J Dis Child. 1957;93(4):375-384.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
It is now possible to distinguish several disorders of blood coagulation within the condition previously designated as hemophilia, and to identify each as being characterized by defective production of thromboplastin. Whether the latter results from a quantitative deficiency in one of several substances or from the presence of an inhibitor of that substance is debated. Matters of terminology also remain unsettled, and the status of still other hemophilialike disorders awaits confirmation. At present, though, three forms of hemophilia are commonly recognized and usually designated antihemophilic globulin (AHG) deficiency, plasma thromboplastin component (PTC) deficiency, or plasma thromboplastin antecedent (PTA) deficiency.1 It is generally agreed that differentiation of these disorders on clinical grounds alone is virtually impossible and that definitive diagnosis, and to a certain extent rational therapy, rests on the results of certain laboratory tests.
In the light of these findings the present study was undertaken to reevaluate those patients
. . . [Full Text PDF of this Article]
Author Affiliations
Cincinnati
Trainee, National Institute of Arthritis and Metabolic Diseases (Dr. Harmon).; From the Children's Hospital Research Foundation and the Department of Pediatrics, University of Cincinnati College of Medicine.
Footnotes
Submitted for publication July 31, 1956; accepted Aug. 31.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
